iFresh, Inc. Signs Letter of Intent to Acquire 75% of Fujian Fuding Seagull Fishing Food Co., Ltd.
Mar 20, 2018 12:30 pm UTC| Business
NEW YORK, March 20, 2018 -- iFresh, Inc. (“iFresh” or “the Company”) (NASDAQ:IFMK), a leading Asian American grocery supermarket chain and online grocer, today announced today that it has signed a non-binding, letter of...
Mar 20, 2018 12:30 pm UTC| Business
All You Need to Know About Ethereum NEW YORK, NY, , March 20, 2018 -- Strategic Coin, a leading crypto-research and advisory company, released parts one and two of its five-part, in-depth research series entitled:...
WisdomTree ETFs Declare Distributions
Mar 20, 2018 12:30 pm UTC| Business
NEW YORK, March 20, 2018 -- WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below: Ticker Fund NameEx-dateRecord DatePay...
Vet Online Supply Chairman Statement of Share Buy-Back
Mar 20, 2018 12:30 pm UTC| Business
KELSEYVILLE, CA, March 20, 2018 -- Vet Online Supply, Inc. (OTC PINK:VTNL) (the Company), announces today the following statement from Daniel Rushford, Chairman of the Board. “The purpose of this announcement is to...
Mar 20, 2018 12:30 pm UTC| Business
IRVINE, Calif., March 20, 2018 -- Corix Bioscience Inc. (OTCQB: CXBS), an emerging developer of proprietary cannabis and industrial hemp strains earmarked specifically for use in important healthcare applications, today...
Grown Rogue Introduces CO2 Cartridges, Featuring a Full Spectrum of Cannabinoids and Terpenes
Mar 20, 2018 12:30 pm UTC| Business
Medford, Oregon , March 20, 2018 -- As a pioneer in developing cannabis products that provide consistent experiences to consumers, Grown Rogue is now making “The Right Experience” products available in CO2 oil cartridge...
Progenics Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
Mar 20, 2018 12:30 pm UTC| Business
NEW YORK, March 20, 2018 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, announced today that Mark...